Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
The possibility is examined that immunomodulatory pharmacotherapy may be clinically useful in managing the pandemic coronavirus disease 2019 (COVID-19), known to result from infection by the severe acute respi